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Why was the cohort set up?
Common health conditions such as heart disease, stroke
and depression are a common cause of chronic suffering
and economic burden worldwide.1 Scotland has a high
prevalence of these conditions, and because of its compara-
tively stable population,2 it provides a useful citizenry to
study their prevalence and impact. Generation Scotland
(GS) is a multi-institutional, cross-disciplinary collabor-
ation aiming to promote research into genetics and health
care throughout Scotland.3 Between 2006 and 2011, GS
undertook its first major study–Generation Scotland:
Scottish Family Health Study1,4 (GS:SFHS). This large,
family-based intensively phenotyped and genotyped popu-
lation cohort was designed to examine a diverse range of
illnesses such as those aforementioned. The work of GS is
especially important to epidemiological research as it
provides a means of separating genetic and shared environ-
mental contributions to common non-communicable dis-
eases. Furthermore, the ability to re-contact GS
participants and obtain broad consent for future use of
their data and samples is especially valuable for prospect-
ive studies associated with health outcomes.
In 2015, a strategic award by the Wellcome Trust pro-
vided funding for ‘STRADL: Stratifying Resilience and
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Depression Longitudinally’. This project aimed to
re-contact participants from GS:SFHS for a further assess-
ment of mental health, specifically depression. Major de-
pressive disorder (MDD) is a leading cause of global
disease burden, with a lifetime prevalence of approxi-
mately 10%.5,6. In coming decades, the prevalence and im-
pact of depression will likely increase,4 making the
understanding of its aetiology of substantial importance to
public health. STRADL was designed to investigate the
aetiology of depression and its stratification, as it is
hypothesized that the diagnosis may group together several
causally distinct but symptomatically related syndromes.7
The increased kinship among STRADL participants cre-
ated a rich dataset to conduct genetic studies of MDD aeti-
ology, in addition to examining the complex genetic and
environmental interactions which may increase risk for dif-
ferent depression phenotypes.
STRADL was also designed to investigate psychological
resilience8–10-the ability to ‘escape’ psychopathology des-
pite exposure to known risk factors. Whereas the investiga-
tion of resilience may be expected to reveal similar results
to studying MDD itself, it has the potential to elucidate
protective factors in MDD, even in at-risk individuals.
Indeed, examining the variability in response to known
MDD risks may not just further our understanding of
MDD; a better understanding of resilience mechanisms
may also inform future interventions long before the devel-
opment of the illness.11 Ultimately, the work of STRADL
has the potential to identify causal mechanisms and path-
ways of depression sub-types and elucidate mechanisms
which give rise to better than expected adjustment.
Who is in the cohort?
The original GS:SFHS protocol and cohort characteristics
have been described extensively elsewhere.1,4 Between 2006
and 2011, 24 084 participants were extensively phenotyped
in addition to providing DNA samples for whole-genome
genotyping. GS:SFHS was largely female (59%), and gener-
ally healthier and wealthier than the Scottish population.
STRADL sought to recruit GS:SFHS participants for a
follow-up assessment of mental health and resilience
(N¼ 24 084). Individuals were eligible to participate if they
had taken part in GS:SFHS, had a Community Heath Index
(CHI) number, were alive and living in Scotland, and had
given consent for re-contact. A total of 21 525 (89%) indi-
viduals from GS:SFHS were eligible for re-contact (Figure 1).
Study packages were sent to potential participants
(N¼ 21 525), which consisted of a study invitation letter,
detailed information sheet and a paper booklet containing
the STRADL questionnaires. Study packages were mailed
by an independent party. Participants were given the
option to complete the questionnaires on paper and return
them via Freepost envelope, or use a given URL link for
online submission. The opportunity to return an e-mail ad-
dress for further contact was also provided.
‘Broad’ consent was obtained from participants, permit-
ting the use of their data for ‘future medical research into
health, illness and medical treatment’ without further specifi-
cation. Participants were informed their data would remain
anonymous and would be added to those already held by GS.
A total of 9618 participants responded (45%) at follow-
up. A total of 2460 families (N¼ 7158 individuals) of be-
tween 2 and 18 family members and 2460 unrelated individ-
uals formed the STRADL cohort. The majority completed
the paper version of the questionnaire (N¼8833), and 8%
completed online (N¼ 785). Henceforth, individuals who
participated in STRADL will be referred to as ‘respondents’,
and those who did not reply will be referred to as ‘non-re-
spondents’. All components of STRADL received formal, na-
tional ethical approval from the NHS Tayside committee on
research ethics (reference 14/SS/0039).
Age and sex information were collected in the
STRADL, and all other demographic data were obtained
from GS:SFHS (Table 1). The STRADL cohort was pre-
dominately female (62%) and were older [mean¼50.48
years, standard deviation (SD)¼ 13.41] than non-respon
dents [mean¼ 44.28, SD¼15.70, t(21457)¼31.25,
P< 0.001, Cohen’s d¼ 0.42) at baseline. STRADL re-
spondents were from less socioeconomically deprived areas
compared with non-respondents (t(19812)¼15.15,
P< 0.001, Cohen’s d¼ 0.21) in the Scottish Index of
Multiple Deprivation (SIMD) 2009.12,13 The STRADL co-
hort was generally healthier and wealthier, with a different
age-sex profile in comparison with GS:SFHS, although im-
portant similarities were apparent (Table 1). Although
STRADL may not be truly representative of the Scottish
population, the sample includes data on participants from
all socioeconomic status strata.
Figure 1. STRADL recruitment flow diagram.
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What has been measured?
A summary of all data collected and their completeness is
shown in Table 2. All data were anonymized using a bar-
code system which linked with a unique participant identi-
fication number at the time of data analysis. Paper
questionnaires were scanned into an electronic database
with detailed in-built validity checks.
Although data collection was largely cross-sectional, re-
peated measures of GS:SFHS measures were collected
which enabled longitudinal examination. Pearson’s
chi-square (v2) tests were conducted to illustrate group dif-
ferences for categorical data during GS:SFHS. As an alter-
native to the independent t test, comparisons between
respondents and non-respondents at baseline are reported
using the Mann–Whitney–Wilcoxon (U) test. Wilcoxon
signed rank (W) tests have been reported for differences be-
tween respondents across GS:SFHS and STRADL as a non-
parametric test equivalent to the dependent ttest.
Calculations for group differences and changes over time
have ignored the relatedness of the sample, which will be
appropriately controlled for in future publication of the
data. These differences are shown in Table 3.
Substance use
At baseline 17% of all participants smoked, although re-
spondents were less likely to smoke (13%) compared with
non-respondents (21%) [v2(1)¼ 260.58, P< 0.001,
r¼ 0.11]. At follow-up, the percentage of respondents smok-
ing increased to 17% [v2(1)¼ 1563.60, P< 0.001, r¼0.60].
At baseline 90% of participants drank alcohol, with re-
spondents more likely to drink alcohol than non-
respondents [v2(1)¼ 5.23, P¼ 0.02, r¼0.02]. Respondents
consumed less units per week (mean¼ 9.64, SD¼ 10.79)
than did non-respondents (mean¼ 10.32, SD¼ 12.25) at
baseline [t(13221)¼ 3.39, P< 0.001, Cohen’s d¼ 0.06], al-
though this difference was small in magnitude. The number
of respondents who drank alcohol decreased at follow-up
[v2(1)¼ 2575.7, P< 0.001, r¼ 0.53]. Respondent alcohol
consumption substantially increased at follow-up
(W¼ 3149600, P< 0.001), although extreme values were
reported (mean¼ 13.91, SD¼ 22.42, range¼0914).
Respondent’s alcohol consumption was moderately corre-
lated between time points (r¼ 0.50).
Mental health assessment
GS:SFHS participants were screened for a lifetime history of
major depressive disorder (MDD) using the Structured
Clinical Interview for DSM-IV Disorders (SCID).14 Although
the SCID has the potential to make inferences on an array of
Axis I disorders, only case/control classifications for MDD
were ascertained. The threshold for lifetime prevalence of
MDD follows Diagnostic and Statistical Manual of Mental
Disorders15 (DSM) criteria. Where symptoms of either de-
pressed mood or anhedonia have been endorsed, a minimum
of four further symptoms must also be endorsed and their
clinical significance confirmed (i.e. symptoms lasting nearly
all day, every day for a minimum period of 2 weeks).
STRADL participants completed the Composite
International Diagnostic Interview–Short Form (CIDI-SF).16
The CIDI-SF is a self-report questionnaire measure of psychi-
atric symptoms, developed from the larger CIDI by the
World Health Organization17 according DSM-IV15 criteria.








Male 54 43 48
Female 52 45 48
Gender (% female) 62 57 59
Employment (those aged up to 75 years) (%)
Unemployed 4 5 5
Retired 18 13 15
Employed (full- or part-time, or self-employed) 71 71 71
Education (%)
Degree 37 28 32
No qualification 7 9 8
Annual income>£30 000 (%) 63 57 60
SIMD 4123 (1777) 3733 (1875) 3910 (1842)
Abbreviations: STRADL, Stratifying Resilience and Depression Longitudinally; GS, Generation Scotland; GS:SFHS, Generation Scotland: the Scottish Family Health
Study; SIMD, the Scottish Index of Multiple Deprivation 2009. With the exception of age and SIMD, values represent percentage; SIMD represents mean rank (SD).
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The CIDI-SF uses a stem-branch logic in which two symp-
tomatic screening questions (symptoms of depressive mood
or anhedonia) must be endorsed and reach clinical signifi-
cance (lasting nearly all day, every day for 2 weeks or more).
A minimum of four other symptoms must also be endorsed
in addition to at least one screening question. Respondents
who meet criteria for lifetime history of MDD reliably meet
full diagnostic criteria with excellent accuracy if given the
long version of CIDI.16 As the CIDI-SF can be completed in
a relatively short period (approximately 10 min), it is a scale-
able and acceptable measure for epidemiological studies.
At baseline, an identical proportion of respondents
(13%) and non-respondents (13%) met criteria for a
lifetime history of MDD as established using the SCID,
[v2(1)¼ 0.55, P¼ 0.457, r¼ 0.01]. In STRADL, 16% of
respondents met the CIDI-SF criteria for lifetime MDD
(N¼ 1506), of whom 16% reported being currently de-
pressed. Lifetime history of MDD was moderately corre-
lated between the two measures (r¼ 0.30).
The General Health Questionnaire-2818 (GHQ-28) was
administered across time points as a tool used to identify
milder psychiatric problems in the general population.19
As psychological distress represents a cluster of emotional
symptoms linked to depression, the GHQ-28 was used
alongside clinical measures to make better distinctions be-
tween syndrome and sub-threshold symptoms.20,21





c. Email address 79.99
2. Medical History
a. Stoke or mini stroke (TIA) 98.55
b. Heart attack or angina 98.44
c. Other heart disease 98.16
d. Pains in leg muscles 98.07
e. Diabetes (blood sugar problems) 98.54
f. High blood pressure 98.47
g. High blood cholesterol 98.03
3. Brief Resilience Scale (BRS) 98.00
4. List of Threatening Experiences (LTE) 99.00
5. Composite International Diagnostic Interview – Short Form (CIDI-SF) 97.08
6. General Health Questionnaire-28 (GHQ-28) 93.94
a. GHQ somatic 98.09
b. GHQ anxiety 98.52
c. GHQ social dysfunction 98.53
d. GHQ depression 95.96
7. Alcohol and tobacco consumption
a. Have you ever smoked tobacco? 99.12
b. Are you a current smoker? 46.20
c. If yes, how many cigarettes do you smoke in an average week? –
d. If yes, how many cigars do you smoke in an average week? –
e. If yes, how many 25g packets of tobacco do you smoke in an average week? –
f. Do you currently drink any alcoholic drinks? 98.22
g. Have you ever felt you should cut down on your drinking? 80.06
h. Have people annoyed you by criticising your dinking? 80.13
i. Have you ever felt bad or guilty about your drinking? 80.06
j. Have you ever had a drink first thing in the morning to steady your nerves or to get rid of a hangover? 80.14
k. In an average week, how many units of alcohol do you consume? 79.67
8. Coping Inventory for Stressful Situations (CISS)
a. Task-oriented coping 93.37
b. Emotion-oriented coping 94.93
c. Avoidance-oriented coping 94.30
d. Distraction 95.47
e. Social Diversion 96.22
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Responses were scored using the Likert method (0-1-2-3)
whereby higher scores represent higher levels of psycho-
logical distress. Individual domain scores gave information
on somatic symptoms, anxiety, social dysfunction and
depression.
Non-respondents experienced more psychological distress
at baseline than respondents (U¼ 44888000, P< 0.001) al-
though levels of psychological distress increased over time in
STRADL respondents (W¼ 9713600, P< 0.001). Total
GHQ score of respondents across time points was moder-
ately correlated (r¼ 0.46).
Symptoms of GHQ depression appeared greater in non-
respondents than respondents at baseline, (U¼44607000,
P< 0.001). GHQ depression scores increased in respond-
ents between time points (W¼ 1409700, P< 0.001). GHQ
depression scores were moderately correlated (r¼ 0.46) in
respondents between assessments.
Symptoms of GHQ anxiety were higher in non-
respondents than respondents at baseline, (U¼45042000,
P< 0.001). Anxiety scores increased in respondents be-
tween time points (W¼ 8937100, P< 0.001), and were
moderately correlated (r¼0.45).
New measures
Questionnaire measures of psychological resilience,22 cop-
ing style,23 threatening life experiences24 and medical con-
ditions were obtained in STRADL, and are summarized in
Tables 4, 5 and 6.
The Brief Resilience Scale22 (BRS) assessed the ability to
‘bounce back’ from stress. Six questions were answered on
a five-point scale from ‘Strongly disagree’ to ‘Strongly
agree’. A total score was calculated as the mean of the six
items, with appropriate reverse scoring of even-numbered
questions. The BRS has previously shown good internal
consistency and test-retest reliability.22
The Coping Inventory for Stressful Situations (CISS)23
was a self-report questionnaire measuring three coping style
scales: task-oriented, emotion-oriented and avoidance-
oriented coping. Two sub-scales of avoidance-oriented cop-
ing were also derived: distraction and social diversion. Each
item was rated on a five-point scale from (1) ‘Not at all’ to
(5) ‘Very much’. The CISS has proven a robust measure of
assessing situation-specific coping strategies, with a stable
factor structure and high construct validity.23,25
The List of Threatening Experiences (LTE)24 was a self-
report measure consisting of 12 common and threatening
life events that may have occurred in the 6 months preced-
ing completion. For each threatening event endorsed, criter-
ion contextual threat ratings are measured on a scale from 3
(‘Very bad’) to 1 (‘Not too bad’). The LTE has been shown
to have excellent test-retest reliability and high sensitivity.26
How often have they been followed up?
STRADL is a mental health questionnaire follow-up of
GS:SFHS. Although data collection was cross-sectional,
STRADL becomes a longitudinal cohort because of NHS
data linkage using Community Health Index (CHI) num-
bers which are allocated to every individual registered with
a GP in Scotland. The ability to link with routinely col-
lected NHS data will allow validation of the self-reported
illness recorded in the study, and provide information on
clinical endpoints and follow-up. Furthermore, the use of
NHS linkage converts this two-phase cohort study into a
potentially lifelong study of resilience and depression.
Table 3. Repeated measures between respondents and non-respondents during GS:SFHS (baselines) and STRADL (follow-up)







Currently smoke (%) 21 13* 17**
Currently drink (%) 90 91* 80**
Alcohol units per week 10.3 (12.3) 9.7 (10.8)* 13.9 (22.4)**
Meets SCID criteria for MDD (%) 13 13 –
Meets CIDI-SF criteria for MDD (%) – – 16
Meets CIDI-SF criteria for bipolar disorder (%) – – 1.3
Meets CIDI-SF criteria for hypomanic episode (%) – – 0.4
Total GHQ score 16.4 (9.1) 15.4 (8.4)* 16.9 (9.3)**
GHQ depression score 0.97 (2.4) 0.80 (2.2)* 1.0 (2.2)**
GHQ anxiety score 4.0 (3.8) 3.6 (3.5)* 4.4 (4.2)**
Abbreviations: GS, Generation Scotland; GS:SFHS, Generation Scotland: the Scottish Family Health Study; STRADL, Stratifying Resilience and Depression
Longitudinally; SCID, Structured Clinical Interview for DSM-IV; MDD, Major Depressive Disorder; CIDI-SF, Composite International Diagnostic Interview –
Short Form; GHQ, General Health Questionnaire. Unless denoted by (%), results represent mean (SD). GHQ scores calculated using the Likert method.
*Significantly different from non-respondents in Wave1 at P<0.05; **significantly different from respondents in Wave 2 at P< 0.05.
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Future parts of the STRADL study will include DNA
methylation analysis and depression-focused neuroimaging
measures of brain structure, function and connectivity.
As with any epidemiological study, a key question is
often whether consenting participants are representative of
the population from which they are drawn. As indicated in
Table 1, STRADL participants appear to be an older,
wealthier, largely female subset of GS:SFHS. This is not
surprising, as these characteristics are associated with
higher response rates to follow-up surveys.27,28 Whereas
results from STRADL may under-represent what would be
Table 4. Respondent results of resilience, coping style and psychological distress testing in STRADL
n Theoretical
maximum score
Mean SD Median Range
BRS 9411 5 2.99 0.36 3 1–5
CISS
Task-oriented 8980 80 54.33 12.28 56 16–80
Emotion-oriented 9130 80 37.61 12.57 37 16–80
Avoidant-oriented 9070 80 39.41 10.52 40 16–80
Distraction-oriented 9182 40 17.46 6.01 17 8–40
Social Diversion-oriented 9254 25 14.33 4.84 15 5–25
GHQ-28
GHQ-aa 9432 21 4.58 3.76 3 0–21
GHQ-ba 9476 21 4.37 4.17 3 0–21
GHQ-ca 9477 21 7.60 2.48 7 0–21
GHQ-da 9229 21 1.01 2.24 0 0–15
GHQ total 9035 84 16.88 9.28 14 0–65
GHQ scores calculated using the Likert method.
Abbreviations: STRADL, Stratifying Resilience and Depression Longitudinally; SD, Standard deviation; BRS, Brief Resilience Scale; CISS, Coping Inventory
for Stressful Situations; GHQ-28, General Health Questionnaire-28.
aGHQ-28 domain scores give information on: (a) somatic symptoms; (b) anxiety/insomnia; (c) social dysfunction; and (d) depression.
Table 5. Results from respondents completing the List of Threatening Experiences summarizing the number of individuals who




Mean SD Median Range
Serious injury or assault to yourself 794 783 3 2.18 0.73 2 1–3
Serious injury or assault to a close relative 1880 1831 3 2.19 0.73 2 1–3
Did a parent, spouse, child or sibling die? 1145 1126 3 2.40 0.71 3 1–3
Close family friend or other relative died 1841 1798 3 1.75 0.74 2 1–3
Separation due to marital difficulties or break of a steady relationship 427 425 3 2.27 0.73 2 1–3
Serious problem(s) with close friend, neighbour or relative 1059 1047 3 2.13 0.68 2 1–3
Made redundant or sacked from job 301 292 3 1.82 0.81 2 1–3
Seeking work unsuccessfully for more than 1 month 367 342 3 1.76 0.73 2 1–3
Major financial crisis (such as losing 3 months’ income) 436 413 3 2.11 0.79 2 1–3
Problems with the police involving court appearance 111 108 3 2.15 0.83 2 1–3
Something of value lost or stolen 372 361 3 1.91 0.76 2 1–3
Yourself or partner gave birth 393 353 3 2.71 0.61 3 1–3
n1, The number of participants who indicated they experienced the event within the past 6 months.
n2, The number of individuals who subsequently gave criterion contextual threat ratings of the event.
Table 6. Self-reported diagnosis of common illnesses among
respondents
n %
Stoke or mini stroke (TIA) 302 3
Heart attack or angina 466 5
Other heart disease 382 4
Pains in leg muscles when walking or in bed at night 1703 18
Diabetes (blood sugar problems) 575 6
High blood pressure 2257 24
High blood cholesterol 1887 20
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reflected in the general Scottish population, the cohort size
results in large amounts of data which represent the full
adult spectrum of ages, sex and demography.
Attrition between time points has been described in
Figure 1. It is possible that the response to STRADL (45%)
is due to a response bias whereby individuals with mental
health difficulties are more likely to respond to a mental
health questionnaire when the purpose has been clearly
communicated. Although the use of paper questionnaires
enables many near-complete participant responses, it is
possible that the majority of potential participants forgot
to complete or return their questionnaire booklets.
It is worth noting the disparity in the proportions of
paper and online responses. Baseline differences between
paper and online respondents are presented in Table 7.
Several reasons have been hypothesized for these differ-
ences. The older demographic of STRADL may have over-
sampled GS:SFHS participants who did not have access to a
personal computer with internet access, or those who were
not confident or willing to complete an online survey.
Furthermore, the URL provided in the written letter was
also very long (53 characters) and it is possible that manu-
ally typing a long URL in a browser’s address bar may have
been intimidating or inconvenient for many respondents, es-
pecially if information technology knowledge was limited.
What has it found? key findings and
publications
Baseline differences between GS:SFHS and STRADL are
summarized above (Tables 1 and 3), and differences be-
tween online and paper respondents are given in Table 7.
This cohort represents a new and potentially valuable data
resource to examine incident depressive symptoms,
longitudinal outcomes and mechanisms of psychological re-
silience. No articles have yet been published with these
data, but the power of this resource is extensive. Genomic
and pedigree-based approaches to these data will enable us
to estimate trait heritability and the contribution of shared
and non-shared environmental effects to depression.29
These data may provide clues as to how people can
modify behaviour to reduce their risk of depression and
psychological distress. Furthermore, STRADL will allow us
to conduct genetic epidemiological analysis on indices of
mental health, building upon existing data held by GS.
What are the main strengths and
weaknesses?
The STRADL cohort includes important phenotypes to
allow population-based genetic and epidemiological research
on the stratification of MDD and resilience. The strengths of
this cohort lie in the repeated assessment of mood disorders,
psychological distress and substance use, making it a valu-
able dataset to investigate the pathogenic mechanisms that
underlie psychopathology, in addition to making longitu-
dinal predictions on depression and resilience. As data can be
linked anonymously to NHS records, STRADL can be con-
verted from a cross-sectional analysis into a longitudinal co-
hort covering a wide range of clinically relevant outcomes.
Furthermore, the availability for longitudinal sampling is of
benefit in obtaining repeated measures of mental health and
resilience that might be missed by a single measure.30,31
Further, specific limitations of this cohort warrant con-
sideration. First, like other population cohorts such as UK
Biobank,32,33 STRADL participants were more likely to be
graduates and to come from less socioeconomically disad-
vantaged areas. Nevertheless, participants from all
Table 7. Some baseline (GS:SFHS) comparisons between STRADL paper and online respondents




Gender (% female) 63 46
Employment (those aged up to 75 years) (%)
Unemployed 4 3
Retired 16 8
Employed (full- or part-time, or self-employed) 73 81
Education (%)
Degree 36 47
No qualification 7 2
Annual income>£30 000 62 74
SIMD 4115 (1777) 421409 (1781)
Abbreviations: GS:SFHS, Generation Scotland: Scottish Family Health Study; STRADL, Stratifying Resilience and Depression Longitudinally; SIMD, the
Scottish Index of Multiple Deprivation 2009. With the exception of age and SIMD, values represent percentage. SIMD represents mean (SD).
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socioeconomic strata were represented in both baseline
(GS:SFHS) and follow-up samples.
Differences in prevalence rates of MDD were found in
STRADL (using the CIDI-SF), compared with the use of
the SCID at baseline. This may be because the SCID is ad-
ministered face-to-face by trained researchers, and may
have better psychometric properties than the self-reported
CIDI-SF.34 However, previous research suggests that the
diagnostic classifications obtained using the CIDI-SF ac-
curately reflect those made in the larger Composite
International Diagnostic Interview.16 In future, the CIDI-
SF will be compared with the SCID and with linked NHS
records so that a comparison of each technique can be
made and potential issues of recall bias can be overcome.
Overall, the GS:SFHS follow-up (STRADL) represents a
valuable resource to investigate the stratification of depres-
sion and mechanisms of psychological resilience in a large,
family-based, cohort.
Can I get hold of the data? where can I find
out more?
Non-identifiable information from this cohort will be
made available to researchers throughout the UK and to
international collaborators, and are available from the GS
Access Committee at [resources@generationscotland.org].
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